(Total Views: 56)
Posted On: 01/30/2025 12:10:06 PM
Post# of 43395

$DYAI Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology
https://finance.yahoo.com/news/dyadic-receive...00271.html
https://finance.yahoo.com/news/dyadic-receive...00271.html


Scroll down for more posts ▼